Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

"This is an area in which we haven't had something we felt hopeful about in a while," professor Joseph Schacht said.

The GLP-1 medications have been linked to decreased risks of heart disease, kidney disease and Alzheimer’s disease, as well as increased fertility and a reduction in alcohol cravings.

Now, researchers at the University of Colorado Anschutz Medical Campus are leading a trial to find out if weight-loss drugs can curb alcohol cravings. "This is an area in which we haven't had ...